202 related articles for article (PubMed ID: 37060529)
1. Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches.
Khan J; Yasinzai AQK; Matosz S; Khan M; Heneidi S; Mesa H; Chauhan A; Del Rivero J; Karim NA; Ullah A
Clin Exp Med; 2023 Nov; 23(7):3947-3955. PubMed ID: 37060529
[TBL] [Abstract][Full Text] [Related]
2. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
3. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
4. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
Rossi G; Cavazza A; Marchioni A; Longo L; Migaldi M; Sartori G; Bigiani N; Schirosi L; Casali C; Morandi U; Facciolongo N; Maiorana A; Bavieri M; Fabbri LM; Brambilla E
J Clin Oncol; 2005 Dec; 23(34):8774-85. PubMed ID: 16314638
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
6. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study.
Niho S; Kenmotsu H; Sekine I; Ishii G; Ishikawa Y; Noguchi M; Oshita F; Watanabe S; Nakajima R; Tada H; Nagai K
J Thorac Oncol; 2013 Jul; 8(7):980-4. PubMed ID: 23774385
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of advanced large cell neuroendocrine carcinoma].
Kishi K; Homma S; Takaya H; Miyamoto A; Sakamoto S; Kurosaki A; Motoi N; Yoshimura K
Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):556-60. PubMed ID: 16972612
[TBL] [Abstract][Full Text] [Related]
9. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
10. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lung large cell neuroendocrine carcinoma.
Lo Russo G; Pusceddu S; Proto C; Macerelli M; Signorelli D; Vitali M; Ganzinelli M; Gallucci R; Zilembo N; Platania M; Buzzoni R; de Braud F; Garassino MC
Tumour Biol; 2016 Jun; 37(6):7047-57. PubMed ID: 26943800
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for patients with large cell neuroendocrine carcinoma of the lung.
Iyoda A; Makino T; Koezuka S; Otsuka H; Hata Y
Gen Thorac Cardiovasc Surg; 2014 Jun; 62(6):351-6. PubMed ID: 24719260
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
[TBL] [Abstract][Full Text] [Related]
14. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
[TBL] [Abstract][Full Text] [Related]
15. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
[TBL] [Abstract][Full Text] [Related]
16. DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.
Ogawa H; Sakai Y; Nishio W; Fujibayashi Y; Nishikubo M; Nishioka Y; Tane S; Kitamura Y; Sudo T; Sakuma T; Yoshimura M
Thorac Cancer; 2020 Sep; 11(9):2561-2569. PubMed ID: 32691982
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
[No Abstract] [Full Text] [Related]
18. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
[TBL] [Abstract][Full Text] [Related]
19. The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung.
Gu J; Gong D; Wang Y; Chi B; Zhang J; Hu S; Min L
Cancer Med; 2019 Jun; 8(6):2979-2993. PubMed ID: 31087628
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
